Boehringer Ingelheim announces collaboration with MabGenesis

Boehringer Ingelheim, a global leader in animal health, and MabGenesis, a private biopharmaceutical company headquartered in Yokohama, Japan, announce that they have entered into a collaboration to discover and develop novel monoclonal antibodies for potential canine therapeutic treatments. Under the agreement, MabGenesis will apply its unique platform to the discovery of first-in-class candidate antibodies against […]

Biovet S.A. renews the Premium agreement with the Chamber of Commerce of Terragona

In recent days, Biovet S.A. has renewed the Premium collaboration agreement that it maintains with the Chamber of Commerce of Tarragona. Both organizations will continue working to promote economic dynamization initiatives, support internationalization actions, as well as advise on the situation of the markets. In the signing meeting, Ms. Laura Roigé, president of the Chamber of Commerce of […]